发明名称 |
TREATMENT OF CANCER WITH A HUMANIZED ANTI-EGFR IGG1 ANTIBODY AND IRINOTECAN. |
摘要 |
<p>The present invention provides a humanized anti-EGFR IgG1 antibody and irinotecan for combined use in treating cancer, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of a combination of a humanized anti-EGFR IgG1 antibody and irinotecan in a pharmaceutically acceptable carrier.</p> |
申请公布号 |
MX2011009620(A) |
申请公布日期 |
2011.10.19 |
申请号 |
MX20110009620 |
申请日期 |
2010.03.26 |
申请人 |
ROCHE GLYCART AG |
发明人 |
PABLO UMANA;THOMAS FRIESS;EKKEHARD MOESSNER |
分类号 |
A61K39/395;A61K31/4745;A61P35/00;C07D491/22;C07K16/28 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|